US Patent 10189833 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Daiichi Sankyo

With Fermion, start the journey of your innovative API.

Contact Supplier

Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

Contact Supplier

dmfs-not-supported-m-2025-06-30

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

veranova-m-2025-06-30

Contact Supplier

jdmfs-not-supported-m-2025-06-30

Daiichi Sankyo

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 694 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
694 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

93 All APIs, 86 USDMF, 4 CEP/COS, 4 JDMF, 6 KDMF, 1 VMF

93 All APIs
86 USDMF
4 CEP/COS
4 JDMF
6 KDMF
1 VMF

DEVELOPMENTS

198 Drugs in Development

198 Drugs in Development

FINISHED DOSAGE FORMULATIONS

109 FDF Dossiers, 18 FDA Orange Book, 88 Europe, 3 Listed Dossiers

109 FDF Dossiers
18 FDA Orange Book
88 Europe
3 Listed Dossiers

INSPECTIONS & REGISTRATIONS

3 FDA

3 FDA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2DAIICHI SANKYO INC

filter Patent Number Reset all filters

2 All

01 210189833

API Patent Reset all filters

2 All

01 2Blank

FDF Patent Reset all filters

2 All

01 2Blank

filter Expiration Date Reset all filters

2 All

01 22036-05-05

01

DAIICHI SANKYO INC

PEXIDARTINIB HYDROCHLORIDE

Discovery Europe

Not Confirmed

DAIICHI SANKYO INC

Discovery Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-05-05

PEXIDARTINIB HYDROCHLORIDE

US Patent Number : 10189833

Drug Substance Claim :

Drug Product Claim :

Application Number : 211810

Patent Use Code : U-2606

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-05-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

DAIICHI SANKYO INC

PEXIDARTINIB HYDROCHLORIDE

Discovery Europe

Not Confirmed

DAIICHI SANKYO INC

Discovery Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-05-05

PEXIDARTINIB HYDROCHLORIDE

US Patent Number : 10189833

Drug Substance Claim :

Drug Product Claim :

Application Number : 211810

Patent Use Code : U-2606

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-05-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!